{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:23:45Z","timestamp":1770827025813,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22207016"],"award-info":[{"award-number":["22207016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejphar.2023.175751","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T20:30:48Z","timestamp":1682541048000},"page":"175751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hybrids of carbonic anhydrase and cyclooxygenase inhibitors attenuate cardiac hypoxic inflammatory injuries"],"prefix":"10.1016","volume":"950","author":[{"given":"Wen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175751_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bioorg.2018.11.033","article-title":"Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: dual cyclooxygenase\/carbonic anhydrase inhibitory actions","volume":"84","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175751_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.175751_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175751_bib4","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/acs.jmedchem.9b01130","article-title":"Bioisosteric development of multitarget nonsteroidal anti-inflammatory Drug\u2212Carbonic anhydrases inhibitor hybrids for the management of rheumatoid arthritis","volume":"63","author":"Bua","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejphar.2023.175751_bib5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/ijms18071540","article-title":"Thrombospondins: a role in cardiovascular disease","volume":"18","author":"Chistiakov","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175751_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2018.04.005","article-title":"Deep learning for healthcare applications based on physiological signals: a review","volume":"161","author":"Faust","year":"2018","journal-title":"Comput. Methods Progr. Biomed."},{"key":"10.1016\/j.ejphar.2023.175751_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2019.12.041","article-title":"Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review","volume":"319","author":"Kumari","year":"2020","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175751_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.175751_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s12276-019-0235-1","article-title":"Hypoxia signaling in human diseases and therapeutic targets","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175751_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175751_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvaa211","article-title":"Inflammation and cardiovascular diseases: lessons from seminal clinical trials","volume":"117","author":"Liberale","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"19","key":"10.1016\/j.ejphar.2023.175751_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021685","article-title":"Emerging therapies for recurrent pericarditis: interleukin-1 inhibitors","volume":"10","author":"Lo Presti","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.ejphar.2023.175751_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.tcb.2016.07.002","article-title":"Physiological and pharmacological control of BAK, BAX, and beyond","volume":"26","author":"Luna-Vargas","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"16","key":"10.1016\/j.ejphar.2023.175751_bib14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175751_bib15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2023.175751_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107624","article-title":"Cyclooxygenases and the cardiovascular system","volume":"217","author":"Mitchell","year":"2021","journal-title":"Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175751_bib17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175751_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10787-019-00653-x","article-title":"Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review","volume":"28","author":"Nomani","year":"2019","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.ejphar.2023.175751_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcm.2019.08.005","article-title":"Modulation of microRNAs by aspirin in cardiovascular disease","volume":"30","author":"Paseban","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175751_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175751_bib21","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/acs.analchem.8b04027","article-title":"Smart plasmonic nanorobot for real-time monitoring cytochrome c release and cell acidification in apoptosis during electrostimulation","volume":"91","author":"Qi","year":"2019","journal-title":"Anal. Chem."},{"issue":"24","key":"10.1016\/j.ejphar.2023.175751_bib22","doi-asserted-by":"crossref","first-page":"E906","DOI":"10.1161\/CIRCULATIONAHA.120.047521","article-title":"Considerations for drug interactions on QTc in exploratory COVID-19 treatment","volume":"141","author":"Roden","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejphar.2023.175751_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175751_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ph9020017","article-title":"Non-steroidal anti-inflammatory drugs and aspirin therapy for the treatment of acute and recurrent idiopathic pericarditis","volume":"9","author":"Schwier","year":"2016","journal-title":"pharmaceuticals-base"},{"key":"10.1016\/j.ejphar.2023.175751_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113975","article-title":"Rapamycin restrains platelet procoagulant responses via FKBP-mediated protection of mitochondrial integrity","volume":"177","author":"Sledz","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175751_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.ejphar.2023.175751_bib27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2023.175751_bib28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"12","key":"10.1016\/j.ejphar.2023.175751_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri.2017.103","article-title":"Regulation of immunity and inflammation by hypoxia in immunological niches","volume":"17","author":"Taylor","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175751_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21 st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175751_bib31","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175751_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172417","article-title":"A novel ferulic acid derivative attenuates myocardial cell hypoxia reoxygenation injury through a succinate dehydrogenase dependent antioxidant mechanism","volume":"856","author":"Wang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejphar.2023.175751_bib33","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1039\/D2SC00048B","article-title":"A hypoxia-activated NO donor for the treatment of myocardial hypoxia injury","volume":"13","author":"Zhou","year":"2022","journal-title":"Chem. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175751_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10557-021-07182-2","article-title":"An original aspirin-containing carbonic anhydrase 9 inhibitor overcomes hypoxia-induced drug resistance to enhance the efficacy of myocardial protection","volume":"36","author":"Zhou","year":"2021","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:22:07Z","timestamp":1762143727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923002625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":34,"alternative-id":["S0014299923002625"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175751","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrids of carbonic anhydrase and cyclooxygenase inhibitors attenuate cardiac hypoxic inflammatory injuries","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175751"}}